Related Articles
Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer
First‑line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study
Gemcitabine in combination with paclitaxel for advanced soft‑tissue sarcomas
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin‑bound paclitaxel for human epidermal growth factor receptor 2‑negative breast cancer
Efficacy and safety of Nivolumab in non‑small cell lung cancer patients in Tel‑Aviv tertiary medical center: Facing the reality